The Patent Finder

Immunitybio, Inc.

90 patents currently held · Updated Nov 14, 2026
27 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded as renamed to Nantcell, Inc. (2021)

Previously recorded as Nantkwest, Inc. (to 2021)

0
Ending by 2030
Oct 2034
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 13, 2026
    The maintenance fee for Methods of Treating Aging-Related Disorders (US 11,672,826) comes due Dec 13, 2026. Unpaid by Jun 14, 2027, it lapses early.
  • 3 fees due Feb 15 to 28, 2027 · next Feb 15
  • 1 fee due Mar 12, 2027
    The maintenance fee for MODIFIED NK-92 haNK003 CELLS FOR THE CLINIC (US 11,753,625) comes due Mar 12, 2027. Unpaid by Sep 13, 2027, it lapses early.
  • 2 fees due Apr 17 to 29, 2027 · next Apr 17
  • 2 fees due May 14 to 21, 2027 · next May 14
  • 1 fee due Jun 30, 2027
    The maintenance fee for Tumoricidal and Antimicrobial Compositions and Methods (US 10,517,895) comes due Jun 30, 2027. Unpaid by Jan 3, 2028, it lapses early.
  • 3 fees due Jul 2 to 30, 2027 · next Jul 2
  • 1 fee due Aug 27, 2027
    The maintenance fee for Nant COVID Vaccine Cross Reactivity (US 11,911,459) comes due Aug 27, 2027. Unpaid by Feb 28, 2028, it lapses early.
  • 1 fee due Sep 19, 2027
    The maintenance fee for Generating Cik NKT Cells from Cord Blood (US 11,931,382) comes due Sep 19, 2027. Unpaid by Mar 20, 2028, it lapses early.
  • 2 fees due Nov 7 to 12, 2027 · next Nov 7

Which patents, and when each one lapses · Pro

Recent changes

  • 4 of the patents on this record were granted since Aug 16, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 10,258,649Tumoricidal and Antimicrobial Compositions and Methods
In force
 · High confidence
In forceHigh confidence
US 10,517,895Tumoricidal and Antimicrobial Compositions and Methods
In force
 · Medium confidence
In forceMedium confidence
US 10,646,516Tumoricidal and Antimicrobial Compositions and Methods
In force
 · High confidence
In forceHigh confidence
US 10,772,912A Tumoricidal and Antimicrobial Composition
In force
 · Medium confidence
In forceMedium confidence
US 11,213,547Tumoricidal and Antimicrobial Compositions and Methods
In force
 · High confidence
In forceHigh confidence
US 11,304,977Tumoricidal and Antimicrobial Compositions and Methods
In force
 · Medium confidence
In forceMedium confidence
US 11,975,027Tumoricidal and Antimicrobial Compositions and Methods
In force
 · Medium confidence
In forceMedium confidence
US 12,064,450Tumoricidal and Antimicrobial Compositions and Methods
In force
 · High confidence
In forceHigh confidence
US 10,456,420Genetically Modified NK-92 Cells and Monoclonal Antibodies for the Treatment of Cancer
In force
 · High confidence
In forceHigh confidence
US 10,774,310MODIFIED NK-92 haNK003 CELLS FOR THE CLINIC
In force
 · High confidence
In forceHigh confidence
10 of 90 patents shown.
Pro members see all 90.
Pro members: see all 90 patents
Also on record, not counted in the 90: 27 patents in force now held by others · 2 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

41 pending · 7 abandoned · 6 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited